Royal London Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,196
| Closed | -$227K | – | 704 |
|
|
2025
Q3 | $227K | Sell |
4,196
-71,832
| -94% | -$4.11M | ﹤0.01% | 672 |
|
|
2025
Q2 | $4.18M | Sell |
76,028
-9,132
| -11% | -$538K | 0.01% | 563 |
|
|
2025
Q1 | $6.02M | Buy |
85,160
+8,301
| +11% | +$558K | 0.01% | 537 |
|
|
2024
Q4 | $5.05M | Sell |
76,859
-486
| -0.6% | -$32.6K | 0.01% | 553 |
|
|
2024
Q3 | $5.44M | Buy |
77,345
+4,058
| +6% | +$339K | 0.01% | 543 |
|
|
2024
Q2 | $6.03M | Buy |
73,287
+1,090
| +2% | +$90.7K | 0.02% | 504 |
|
|
2024
Q1 | $6.31M | Sell |
72,197
-1,620
| -2% | -$145K | 0.02% | 504 |
|
|
2023
Q4 | $7.12M | Buy |
73,817
+1,917
| +3% | +$170K | 0.02% | 465 |
|
|
2023
Q3 | $6.36M | Buy |
71,900
+3,624
| +5% | +$322K | 0.02% | 457 |
|
|
2023
Q2 | $5.92M | Buy |
68,276
+5,444
| +9% | +$512K | 0.02% | 472 |
|
|
2023
Q1 | $6.11M | Sell |
62,832
-1,070
| -2% | -$111K | 0.02% | 419 |
|
|
2022
Q4 | $6.61M | Hold |
63,902
| – | – | 0.03% | 398 |
|
|
2022
Q3 | $5.42M | Sell |
63,902
-277
| -0.4% | -$24.7K | 0.03% | 412 |
|
|
2022
Q2 | $5.32M | Sell |
64,179
-121
| -0.2% | -$9.63K | 0.02% | 433 |
|
|
2022
Q1 | $4.96M | Buy |
64,300
+3,597
| +6% | +$301K | 0.02% | 501 |
|
|
2021
Q4 | $5.37M | Sell |
60,703
-2,119
| -3% | -$175K | 0.02% | 471 |
|
|
2021
Q3 | $4.86M | Sell |
62,822
-2,078
| -3% | -$164K | 0.02% | 493 |
|
|
2021
Q2 | $5.42M | Hold |
64,900
| – | – | 0.02% | 489 |
|
|
2021
Q1 | $4.9M | Hold |
64,900
| – | – | 0.02% | 498 |
|
|
2020
Q4 | $5.69M | Sell |
64,900
-359
| -0.6% | -$28.5K | 0.03% | 410 |
|
|
2020
Q3 | $4.96M | Sell |
65,259
-26
| -0% | -$2.63K | 0.03% | 404 |
|
|
2020
Q2 | $7.98M | Sell |
65,285
-4,226
| -6% | -$420K | 0.06% | 293 |
|
|
2020
Q1 | $5.73M | Hold |
69,511
| – | – | 0.05% | 328 |
|
|
2019
Q4 | $5.88M | Hold |
69,511
| – | – | 0.04% | 374 |
|
|
2019
Q3 | $4.69M | Sell |
69,511
-802
| -1% | -$61.8K | 0.04% | 433 |
|
|
2019
Q2 | $6.02M | Hold |
70,313
| – | – | 0.06% | 317 |
|
|
2019
Q1 | $6.24M | Sell |
70,313
-6,379
| -8% | -$591K | 0.05% | 361 |
|
|
2018
Q4 | $6.41M | Buy |
76,692
+4,842
| +7% | +$461K | 0.06% | 338 |
|
|
2018
Q3 | $6.97M | Sell |
71,850
-336
| -0.5% | -$33.5K | 0.07% | 271 |
|
|
2018
Q2 | $6.8M | Buy |
+72,186
| New | +$6.32M | 0.07% | 298 |
|
|
2016
Q2 | $4.32M | Sell |
55,482
-3,085,046
| -98% | -$262M | 0.07% | 290 |
|
|
2016
Q1 | $38K | Buy |
3,140,528
+3,084,821
| +5,538% | +$251M | 0.05% | 357 |
|
|
2015
Q4 | $5.89M | Sell |
55,707
-749
| -1% | -$78.2K | 0.09% | 237 |
|
|
2015
Q3 | $5.95M | Buy |
+56,456
| New | +$7.54M | 0.1% | 226 |
|
|
2014
Q4 | $42K | Buy |
46,488
+12,066
| +35% | +$1M | 0.08% | 271 |
|
|
2014
Q3 | $2.51M | Buy |
34,422
+2,075
| +6% | +$136K | 0.06% | 317 |
|
|
2014
Q2 | $2.11M | Sell |
32,347
-133
| -0.4% | -$8.04K | 0.05% | 392 |
|
|
2014
Q1 | $1.93M | Buy |
+32,480
| New | +$2.39M | 0.04% | 426 |
|
Other funds holding BMRN
